Loading clinical trials...
Loading clinical trials...
FIRST-2.5: Finerenone Research of Early Safety and Effectiveness, Part 2.5
Conditions
Interventions
Finerenone (Kerendia, BAY948862)
Others except finerenone
Locations
1
United States
Bayer
Whippany, New Jersey, United States
Start Date
October 9, 2024
Primary Completion Date
March 31, 2025
Completion Date
June 30, 2026
Last Updated
April 13, 2026
NCT07547098
NCT07232537
NCT06278207
NCT07493642
NCT07241390
NCT07051005
Lead Sponsor
Bayer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions